Levofloxacin Aspire Pharma

Levofloxacin, the active ingredient in Levofloxacin Aspire Pharma, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in patients requiring topical therapy.

GNH USA supplies Levofloxacin Aspire Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin Aspire Pharma is a fluoroquinolone antibiotic used for bacterial eye infections. - Bacterial conjunctivitis: reduces bacterial load and promotes resolution of conjunctival inflammation. - Bacterial keratitis: eradicates causative organisms and supports corneal healing. - Other bacterial ocular infections: provides broad‑spectrum coverage against susceptible Gram‑negative and Gram‑positive pathogens.

Levofloxacin Aspire Pharma may cause ocular and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation upon instillation. - Redness of the conjunctiva. - Transient blurred vision. - Mild eye irritation or foreign‑body sensation. - Localized itching. - Temporary tearing.

Serious or Rare Side Effects: - Corneal ulceration or perforation. - Severe allergic reaction (anaphylaxis, angioedema). - Tendon rupture (systemic exposure). - Central nervous system effects (seizures, confusion). - Phototoxicity of the ocular surface. - Development of resistant bacterial strains.

Levofloxacin Aspire Pharma should be used with caution in specific situations. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: assess risk versus benefit before use. - Pre‑existing corneal disease: monitor closely for delayed healing. - Concomitant use of other ophthalmic agents: avoid mixing unless directed. - Systemic fluoroquinolone exposure: consider potential tendon or CNS effects. - Store at room temperature: keep in original container, protect from moisture and light.

Levofloxacin Aspire Pharma can interact with other medicines.

Major Interactions (Avoid): - Systemic fluoroquinolones: additive risk of tendon rupture. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of corneal complications.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce drug absorption. - Corticosteroid eye preparations: heightened risk of secondary infection. - Herbal supplements containing quinine: potential additive QT prolongation.